| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics, Inc. | Chief Financial Officer | $6.04M | Aug 9, 2023 | ||
| ARNA | ARENA PHARMACEUTICALS INC | EVP & Chief Financial Officer | Mar 11, 2022 | |||
| PMVP | PMV Pharmaceuticals, Inc. | Director | Jun 5, 2025 | |||
| SION | Sionna Therapeutics, Inc. | Director | Jun 12, 2025 | |||
| SYRE | Spyre Therapeutics, Inc. | Director | May 29, 2025 | |||
| SURF | Surface Oncology, Inc. | Director | Jun 8, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|